eVEGF
Alternative Names: VEGF-A, VPF, glioma-derived endothelial cell mitogen, VEGF-A, VPF, glioma-derived endothelial cell mitogen.
- Sku: PSB-cyt-1200-10µg
- Vendor: ProSpec-Tany
Contact us directly for international purchases.
Product Description
Recombinant Equine Vascular Endothelial Growth Factor (VEGF) is a member of the VEGF family, which plays a key role in angiogenesis and vasculogenesis. This protein is responsible for stimulating the growth of new blood vessels from pre-existing vessels. Recombinant Equine VEGF has a molecular weight of approximately 40 kDa and is commonly used in research and therapeutic applications related to vascular development and regeneration in horses.
Current Lead Time
7-14 Days
Product Specifications
Species |
Horse |
Expression System | E. coli |
Purity | 95% by SDS-PAGE |
Activity |
The ED50 as determined by HUVEC Proliferation is ≤ 10 ng/mL, corresponding to a specific activity of ≥ 1.0 x 10^5 units/mg. |
Activity Assay | |
Animal Component Free (ACF) | Yes |
Molecular Weight |
N/A |
Structure | Dimer |
Endotoxin Concentration |
Not Available |
Purification Method | Not Available |
Form |
Lyophilized |
Formulation | Lyophilized from a sterile (0.2 micron) filtered aqueous solution containing 10 mM Sodium Phosphate, pH 7.5. |
*For Research Use Only
If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation.
Have a question?
eVEGF